• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

爱沙尼亚和拉脱维亚注射吸毒者中IGRA阳性的患病率及结核病危险因素

Prevalence of IGRA-positivity and risk factors for tuberculosis among injecting drug users in Estonia and Latvia.

作者信息

Rüütel Kristi, Karnite Anda, Talu Ave, Abel-Ollo Katri, Kirvelaite Gunta, Kliiman Kai, Loit Helle-Mai, Uusküla Anneli

机构信息

National Institute for Health Development, 42 Hiiu Street, Tallinn, Estonia.

Department of Public Health and Epidemiology, Riga Stradins University, Kronvalda Boulevard 9, Riga, Latvia.

出版信息

Int J Drug Policy. 2014 Jan;25(1):175-8. doi: 10.1016/j.drugpo.2013.10.002. Epub 2013 Oct 16.

DOI:10.1016/j.drugpo.2013.10.002
PMID:24210296
Abstract

BACKGROUND

Illegal drug use and HIV are independent risk factors for tuberculosis (TB) among injecting drug users (IDU). Estonia and Latvia have experienced high rates of TB as well as IDU and HIV outbreaks. There is a lack of knowledge about TB among IDUs in these countries. The purpose of the current study was to estimate the prevalence and risk factors of Mycobacterium tuberculosis (MTB) infection among IDUs in Estonia and Latvia.

METHODS

Participants for this cross-sectional study were recruited from syringe exchange programmes using respondent-driven sampling. For assessing infection with MTB interferon-gamma release assay (IGRA) was used.

RESULTS

The study included 375 participants from Estonia and 313 from Latvia. The prevalence of IGRA-positivity among IDUs was 7.7% in Estonia and 25.6% in Latvia. HIV-prevalence was 62% in Estonia and 23% in Latvia. In both countries, IGRA-positivity rates did not differ between HIV-positive and HIV-negative participants. IGRA-positivity was independently associated with a prior diagnosis of TB in Estonia and with imprisonment (ever within a lifetime) and preceding contact with a TB patient in Latvia.

CONCLUSION

Our findings indicate there is an urgent need for a more vigorous approach in providing IDUs with TB screening services.

摘要

背景

在注射吸毒者(IDU)中,非法药物使用和艾滋病毒是结核病(TB)的独立危险因素。爱沙尼亚和拉脱维亚经历了高结核病发病率以及注射吸毒者和艾滋病毒疫情的爆发。这些国家的注射吸毒者对结核病缺乏了解。本研究的目的是估计爱沙尼亚和拉脱维亚注射吸毒者中结核分枝杆菌(MTB)感染的患病率和危险因素。

方法

本横断面研究的参与者通过应答者驱动抽样从注射器交换项目中招募。使用干扰素-γ释放试验(IGRA)评估MTB感染情况。

结果

该研究包括来自爱沙尼亚的375名参与者和来自拉脱维亚的313名参与者。爱沙尼亚注射吸毒者中IGRA阳性率为7.7%,拉脱维亚为25.6%。爱沙尼亚艾滋病毒患病率为62%,拉脱维亚为23%。在这两个国家,艾滋病毒阳性和阴性参与者之间的IGRA阳性率没有差异。在爱沙尼亚,IGRA阳性与先前的结核病诊断独立相关,在拉脱维亚与监禁(一生中曾有过)和之前与结核病患者接触独立相关。

结论

我们的研究结果表明,迫切需要采取更积极的方法为注射吸毒者提供结核病筛查服务。

相似文献

1
Prevalence of IGRA-positivity and risk factors for tuberculosis among injecting drug users in Estonia and Latvia.爱沙尼亚和拉脱维亚注射吸毒者中IGRA阳性的患病率及结核病危险因素
Int J Drug Policy. 2014 Jan;25(1):175-8. doi: 10.1016/j.drugpo.2013.10.002. Epub 2013 Oct 16.
2
High prevalence of latent tuberculosis infection among injection drug users in Tijuana, Mexico.墨西哥蒂华纳市注射吸毒者中潜伏性结核感染的高流行率。
Int J Tuberc Lung Dis. 2009 May;13(5):626-32.
3
Risk for Heterosexual HIV Transmission Among Non-Injecting Female Partners of Injection Drug Users in Estonia.爱沙尼亚注射吸毒者的异性性伴侣中异性间 HIV 传播的风险。
AIDS Behav. 2013 Mar;17(3):879-88. doi: 10.1007/s10461-011-0078-9.
4
High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment.爱沙尼亚注射吸毒者中艾滋病毒高流行率:对理解风险环境的启示
AIDS. 2006 Oct 24;20(16):2120-3. doi: 10.1097/01.aids.0000247586.23696.20.
5
High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.毛里求斯注射吸毒者中 HIV 和丙型肝炎感染率高:一项基于人口规模估计和应答者驱动抽样调查的研究结果。
Int J Drug Policy. 2011 Jul;22(4):252-8. doi: 10.1016/j.drugpo.2011.05.007. Epub 2011 Jun 22.
6
HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.HIV 感染与爱沙尼亚塔林地区原发性芬太尼和苯丙胺注射者的危险行为:干预意义。
Int J Drug Policy. 2010 Jan;21(1):56-63. doi: 10.1016/j.drugpo.2009.02.007. Epub 2009 Apr 22.
7
Knowledge of HIV serostatus and risk behaviour among injecting drug users in Estonia.爱沙尼亚注射吸毒者的艾滋病毒血清状况及风险行为相关知识
AIDS Care. 2009 Jul;21(7):851-7. doi: 10.1080/09540120802657522.
8
Latent tuberculosis among injection drug users in a methadone maintenance treatment program, Taipei, Taiwan: TSPOT.TB versus tuberculin skin test.台湾台北市美沙酮维持治疗项目中注射吸毒者的潜伏性结核:TSPOT.TB与结核菌素皮肤试验对比
Scand J Infect Dis. 2013 Jul;45(7):504-11. doi: 10.3109/00365548.2013.768354.
9
Tuberculosis knowledge among injecting drug users visiting syringe exchange programme in Tallinn, Estonia.爱沙尼亚塔林访问注射器交换项目的注射吸毒者的结核病知识
Cent Eur J Public Health. 2012 Dec;20(4):248-51. doi: 10.21101/cejph.a3802.
10
HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.HIV 感染者和风险、预防、以及注射吸毒者的检测行为——全国 HIV 行为监测系统,2009 年,美国 20 个城市。
MMWR Surveill Summ. 2014 Jul 4;63(6):1-51.

引用本文的文献

1
Latent Tuberculosis Infection and Associated Risk Factors among People Living with HIV and HIV-Uninfected Individuals in Lithuania.立陶宛艾滋病毒感染者和未感染艾滋病毒个体中的潜伏性结核感染及相关危险因素
Pathogens. 2023 Jul 28;12(8):990. doi: 10.3390/pathogens12080990.
2
Risk for latent and active tuberculosis in Germany.德国潜伏性和活动性肺结核的风险。
Infection. 2017 Jun;45(3):283-290. doi: 10.1007/s15010-016-0963-2. Epub 2016 Nov 19.